Award

NP35925 Cardiovascular & Respiratory Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

This public procurement record has 2 releases in its history.

Award

06 May 2025 at 11:14

Tender

21 Oct 2024 at 14:00

Summary of the contracting process

In the recent procurement process led by The Common Services Agency, known as NHS National Services Scotland (NSS), a contract was awarded for supplying Cardiovascular and Respiratory Medicines under the title "NP35925". The procurement falls into the pharmaceutical industry category, specifically covering goods and was conducted via an open procedure. Key dates include the award date on 7th April 2025, with a framework agreement duration spanning 36 months, extendable by an additional 24 months. Locations involved in the delivery include various regions within Scotland, ensuring broad NHS coverage under the entities established by the National Health Service (Scotland) Act and integrated joint boards. This tender involved multiple lots and aimed to contract with a maximum of six suppliers per framework agreement for each product line, focusing on both logistics and price evaluation criteria.

This tender presents significant opportunities for businesses specializing in pharmaceutical goods, particularly those offering innovative cardiovascular and respiratory medicine solutions. With a substantial estimated contract value and structured multi-supplier framework agreements, it is an excellent opportunity for large pharmaceutical companies to bolster their presence in the UK healthcare market. Companies with capabilities in logistics and competitive pricing will find this tender particularly advantageous. Additionally, the tender encourages participants to support community benefits alongside NHS Scotland’s initiatives, thus appealing to companies that focus on sustainability and community engagement strategies. By participating, businesses can leverage this contract to expand their market reach and enhance their service offerings to a critical segment of the healthcare sector in Scotland.

Find more tenders on our Open Data Platform.

How relevant is this notice?

Notice Information

Get alerts for notices like these

Notice Title

NP35925 Cardiovascular & Respiratory Medicines

Notice Description

This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Information

Epoprostenol Powder and Solvent (pH 10.5) for Solution for Infusion Vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epinephrine (Adrenaline) Pre-Filled Syringes

Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epinephrine (Adrenaline) Auto Injector Devices

Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Enoxaparin Sodium Injection

Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Urokinase Injections

Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets

Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets

Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets

Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Nifedipine Modified-Release (M/R) Capsules and Tablets

Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Theophylline Modified-Release (M/R) Capsules and Tablets

Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Branded and Branded Generic Inhalers

Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Iloprost Medicines

Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Dalteparin Injections

Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Tinzaparin Sodium Injections

Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a lot basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Icatibant Solution for Injection

Supply of Icatibant Solution for Injection to NHS Scotland. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Treprostinil Injection

Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority intends awarding an unranked multi supplier framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Direct Acting Oral Anticoagulants (DOACs)

Supply of Direct Acting Oral Anticoagulants (DOACs) to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

All Other Cardiovascular & Respiratory Medicines

Supply of All Other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line will be treated as an individual Lot. The Authority intends awarding each product line to a single Framework Participant. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Get alerts for notices like these

Publication & Lifecycle

Open Contracting ID: ocds-h6vhtk-04afa6
Publication Source: Find A Tender Service
Latest Notice: https://www.find-tender.service.gov.uk/Notice/019020-2025
Current Stage: Award
All Stages: Tender, Award

Procurement Classification

Notice Type: Tender Notice
Procurement Type: Framework
Procurement Category: Goods
Procurement Method: Open
Procurement Method Details: Open procedure
Tender Suitability: Not specified
Awardee Scale: Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions: 33 - Medical equipments, pharmaceuticals and personal care products
CPV Codes: 33600000 - Pharmaceutical products

Notice Value(s)

Tender Value: £95,148,458 £10M-£100M
Lots Value: £95,148,450 £10M-£100M
Awards Value: Not specified
Contracts Value: £82,305,880 £10M-£100M

Notice Dates

Publication Date: 6 May 20251 years ago
Submission Deadline: 20 Nov 2024Expired
Future Notice Date: Not specified
Award Date: 7 Apr 20251 years ago
Contract Period: Not specified - Not specified
Recurrence: Not specified

Notice Status

Tender Status: Complete
Lots Status: Active, Cancelled
Awards Status: Active
Contracts Status: Active

Buyer & Supplier

Get alerts for notices like these

Contracting Authority (Buyer)

Main Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name: Available with D3 Tenders Premium →
Contact Email: Available with D3 Tenders Premium →
Contact Phone: Available with D3 Tenders Premium →

Buyer Location

Locality: EDINBURGH
Postcode: EH12 9EB
Postcode Area: Edinburgh
Country: Scotland
Major Region (ITL 1): TLM Scotland
Basic Region (ITL 2): TLM1 East Central Scotland
Small Region (ITL 3): TLM13 City of Edinburgh
Delivery Location: TLM Scotland
Local Authority: City of Edinburgh
Electoral Ward: Drum Brae/Gyle
Westminster Constituency: Edinburgh South West

Supplier Information

Number of Suppliers

42

Supplier Names

Accord

Aguettant Ltd

Aspire

Aventis Pharma Ltd t/a Sanofi

Bowmed Ibisqus Limited

Bristol Laboratories

CST Pharma Ltd

Celix Pharma Ltd.

Chiesi Limited

Colonis Pharma Ltd

Consilient Health Ltd

Day Lewis Medical Ltd

Dr Reddy's Laboratories (UK) Ltd

Focus Pharmaceuticals Ltd

Galvany Pharma

Gennisium Pharma SAS

GlaxoSmithKline

Glenmark Pharmaceuticals Europe Ltd

Grindeks Kalceks

Hikma Pharmaceutical International Limited

Kent Pharmaceuticals Ltd

MSN Labs

Macure Pharma Aps

Martindale Pharma

Mercury Pharmaceuticals Limited

Morningside Pharmaceuticals Limited

Northumbria Healthcare NHS Foundation Trust

Perennial Pharma Ltd

Pfizer Limited

Ranbaxy (UK) Ltd

Rosemont Pharmaceuticals Ltd

STADA UK - Thornton & Ross

Sandoz

Selective Supplies Ltd

Stirling Anglian Pharmaceuticals

SyriMed

Techdow Pharma England Ltd

Venipharm LTD

Viatris UK Healthcare Ltd

Wockhardt UK Limited

Zentiva Pharma UK Ltd

hameln pharma ltd

Further Information

Notice URLs

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...

Get an email alert for notices like this

Start your 7-day free trial of D3 Tenders Premium.

Start Free Trial